PTCT

PTC Therapeutics (PTCT)

About PTC Therapeutics (PTCT)

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.

Details

Daily high

$39.22

Daily low

$38.29

Price at open

$38.48

52 Week High

$41.81

52 Week Low

$17.53

Market cap

3.0B

Dividend yield

0.00%

Volume

810,649

Avg. volume

827,830

P/E ratio

-6.17

PTC Therapeutics News